Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Albelda

Showing results (91-100 of 197) with videos related to

Pageof 20
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 21, 2006
Blockade of TNF-alpha decreases both inflammation and efficacy of intrapulmonary Ad.IFNbeta immunotherapy in an orthotopic model of bronchogenic lung cancerMichael J Wilderman, Samuel Kim, Collin T Gillespie, et al.
Journal for Immunotherapy of Cancer|October 8, 2020
Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanomaJeffrey C Thompson, Christiana Davis, Charuhas Deshpande, et al.
American Journal of Respiratory Cell and Molecular Biology|April 17, 2010
Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cellsZvi G Fridlender, Veena Kapoor, George Buchlis, et al.
The Journal of Clinical Investigation|September 11, 2013
Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumorsKwan-Hyuck Baek, Dongha Bhang, Alexander Zaslavsky, et al.
Cancer Biology & Therapy|July 25, 2003
Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profilingSunil Singhal, Kunjlata M Amin, Robert Kruklitis, et al.
BMC Immunology|July 20, 2013
The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T cellsJon G Quatromoni, Eiji Suzuki, Olugbenga Okusanya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancersAfrica Wallace, Veena Kapoor, Jing Sun, et al.
Cancer Immunology Research|April 30, 2014
T cells expressing chimeric antigen receptors can cause anaphylaxis in humansMarcela V Maus, Andrew R Haas, Gregory L Beatty, et al.
Cancers|August 29, 2024
Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line PatientsJeffrey C Thompson, Caitlin Tilsed, Christiana Davis, et al.
Cancer Research|April 12, 2013
Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinasesMatthew J Riese, Liang-Chuan S Wang, Edmund K Moon, et al.
Pageof 20

Showing results (91-100 of 197) with videos related to

Sort By:
Pageof 20
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 21, 2006
Blockade of TNF-alpha decreases both inflammation and efficacy of intrapulmonary Ad.IFNbeta immunotherapy in an orthotopic model of bronchogenic lung cancerMichael J Wilderman, Samuel Kim, Collin T Gillespie, et al.
Journal for Immunotherapy of Cancer|October 8, 2020
Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanomaJeffrey C Thompson, Christiana Davis, Charuhas Deshpande, et al.
American Journal of Respiratory Cell and Molecular Biology|April 17, 2010
Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cellsZvi G Fridlender, Veena Kapoor, George Buchlis, et al.
The Journal of Clinical Investigation|September 11, 2013
Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumorsKwan-Hyuck Baek, Dongha Bhang, Alexander Zaslavsky, et al.
Cancer Biology & Therapy|July 25, 2003
Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profilingSunil Singhal, Kunjlata M Amin, Robert Kruklitis, et al.
BMC Immunology|July 20, 2013
The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T cellsJon G Quatromoni, Eiji Suzuki, Olugbenga Okusanya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancersAfrica Wallace, Veena Kapoor, Jing Sun, et al.
Cancer Immunology Research|April 30, 2014
T cells expressing chimeric antigen receptors can cause anaphylaxis in humansMarcela V Maus, Andrew R Haas, Gregory L Beatty, et al.
Cancers|August 29, 2024
Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line PatientsJeffrey C Thompson, Caitlin Tilsed, Christiana Davis, et al.
Cancer Research|April 12, 2013
Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinasesMatthew J Riese, Liang-Chuan S Wang, Edmund K Moon, et al.
Pageof 20